Riociguat

Sort by

1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-ca...

  • CAT Number DCTI-C-431
  • CAS Number NA
  • Molecular Formula C14H12FN5 (Free Base) C14H13ClFN5 (HCl Salt)
  • Molecular Weight 269.28 (Free Base) 305.74 (HCl Salt)

1-(4-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-ca...

  • CAT NUMBER DCTI-C-432
  • CAS NUMBER NA
  • MOLECULAR FORMULA C14H12FN5 (Free Base); C14H13ClFN5 (HCl Salt)
  • MOLECULAR WEIGHT 269.28 (Free Base); 305.74 (HCl Salt)

1-benzyl-1H-pyrazolo[3,4-b]pyridine-3-carboximidam...

  • CAT Number DCTI-C-433
  • CAS Number NA
  • Molecular Formula C14H13N5 (Free Base) C14H14ClN5 (HCl Salt)
  • Molecular Weight 251.29 (Free Base) 287.75 (HCl Salt)

Riociguat D3

  • CAT NUMBER DCTI-A-410
  • CAS NUMBER 1304478-72-5
  • MOLECULAR FORMULA C20H16D3FN8O2
  • MOLECULAR WEIGHT 425.44

Riociguat EP impurity D

  • CAT NUMBER DCTI-C-3931
  • CAS NUMBER 625115-54-0
  • MOLECULAR FORMULA C22H23FN8O2
  • MOLECULAR WEIGHT 450.48

Riociguat Impurity 10

  • CAT NUMBER DCTI-C-3674
  • CAS NUMBER NA
  • MOLECULAR FORMULA C20H20N8O2
  • MOLECULAR WEIGHT 404.43

Riociguat Impurity-14

  • CAT NUMBER DCTI-C-3295
  • CAS NUMBER 1361569-23-4
  • MOLECULAR FORMULA C20H17FN8O
  • MOLECULAR WEIGHT 404.41

Riociguat Metabolite M3

  • CAT NUMBER DCTI-C-3736
  • CAS NUMBER 2298383-24-9
  • MOLECULAR FORMULA C13H14N8O2
  • MOLECULAR WEIGHT 314.31

Riociguat Methyl Dihydropurinone

  • CAT NUMBER DCTI-C-3690
  • CAS NUMBER 1361569-18-7
  • MOLECULAR FORMULA C19H15FN8O
  • MOLECULAR WEIGHT 390.38
LOAD MORE
You're viewed 9 of 11 products

General Information

Riociguat Impurities and Riociguat 

Daicel Pharma offer Riociguat impurity standards that include 1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [m-Fluro FPC], 1-(4-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [P-Fluro FPC], and 1-benzyl-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [Desfluro FPC]. They are vital to the quality, stability, safety, and efficient analysis of Riociguat. Daicel Pharma also provides custom synthesis for Riociguat and delivers it globally.

Riociguat [CAS: 625115-55-1] is an organofluorine compound and a carbamate ester. It acts as a soluble guanylate cyclase activator and an antihypertensive drug.

Riociguat: Use and Commercial Availability 

Riociguat treats patients with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following surgical treatment or inoperable CTEPH to enhance exercise capacity. This drug is available under the brand name Adempas.

Riociguat Structure and Mechanism of Action Riociguat Structure and Mechanism of Action

The chemical name of Riociguat is Methyl [4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]methylcarbamate. Its chemical formula is C20H19FN8O2, and its molecular weight is approximately 422.4 g/mol.

Riociguat stimulates an enzyme of the cardiopulmonary system, soluble guanylate cyclase (sGC). It increases the generation of cGMP and vasodilation.

Riociguat Impurities and Synthesis

Riociguat may contain impurities that arise during manufacturing or from degradation. These impurities are closely monitored and controlled to ensure product quality and safety. Manufacturers employ purification methods and conduct rigorous analytical testing to minimize impurity levels. Regulatory authorities set limits for specific impurities in Riociguat to meet regulatory requirements.

Daicel Pharma offers a Certificate of Analysis (CoA) for Riociguat impurity standards that include 1-(3-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [m-Fluro FPC], 1-(4-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [P-Fluro FPC], and 1-benzyl-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride [Desfluro FPC]. Daicel’s cGMP-certified analytical facility provides a comprehensive CoA with detailed characterization data like 1H NMR, 13C NMR, IR, MASS, and HPLC purity. Additional characterizations like 13C-DEPT are available upon request. We offer Riociguat impurities and degradation products.

References
FAQ's

Frequently Asked Questions

Controlling Riociguat impurities is essential for drug safety, quality, and efficacy.

Various analytical techniques identify and characterize impurities. Impurities are properly quantified using reference standards and verified analytical procedures.

Various strategies are applied to control and minimize impurities during synthesis. It includes employing high-quality starting materials, following proper purification procedures, and performing quality control testing.

Riociguat impurities should be stored at a controlled room temperature between 2-8°C or as indicated on the Certificate of Analysis (CoA).

Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.

Back to Top
Product has been added to your cart